BankPlus Trust Department’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.97M Buy
5,809
+127
+2% +$130K 1.63% 6
2026
Q1
$5.23M Sell
5,682
-1,495
-21% -$1.52M 1.4% 8
2025
Q4
$7.71M Sell
7,177
-194
-3% -$185K 2.02% 6
2025
Q3
$5.62M Sell
7,371
-203
-3% -$151K 1.51% 8
2025
Q2
$5.9M Buy
7,574
+189
+3% +$147K 1.75% 7
2025
Q1
$6.1M Sell
7,385
-236
-3% -$196K 2.04% 7
2024
Q4
$5.88M Buy
+7,621
New +$6.31M 1.93% 6

Other funds holding LLY

BankPlus Trust Department's LLY Position: Q2 2026 in Review

BankPlus Trust Department increased its Eli Lilly (LLY) stake by 2.2% in Q2 2026, buying an estimated $130K and bringing the position to 5,809 shares worth $6.97M. The position accounts for 1.63% of the portfolio, ranked #6.

BankPlus Trust Department first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.71M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BankPlus Trust Department held 5,809 shares of Eli Lilly worth $6.97M as of Q2 2026.
  • BankPlus Trust Department bought 127 Eli Lilly shares in Q2 2026, an estimated $130K.
  • Eli Lilly made up 1.63% of BankPlus Trust Department's portfolio in Q2 2026, its #6 holding.
  • BankPlus Trust Department first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • BankPlus Trust Department's Eli Lilly position peaked at $7.71M in Q4 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BankPlus Trust Department's 13F filing for Q2 2026, filed 28 Jul 2026.